E3 ubiquitin ligases

被引:271
|
作者
Ardley, HC [1 ]
Robinson, PA [1 ]
机构
[1] Univ Leeds, Mol Med Unit, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
关键词
D O I
10.1042/EB0410015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The selectivity of the ubiquitin-26 S proteasome system (UPS) for a particular substrate protein relies on the interaction between a ubiquitin-conjugating enzyme (E2, of which a cell contains relatively few) and a ubiquitin-protein ligase (E3, of which there are possibly hundreds). Post-translational modifications of the protein substrate, such as phosphorylation or hydroxylation, are often required prior to its selection. In this way, the precise spatio-temporal targeting and degradation of a given substrate can be achieved. The E3s are a large, diverse group of proteins, characterized by one of several defining motifs. These include a HECT (homologous to E6-associated protein C-terminus), RING (really interesting new gene) or U-box (a modified RING motif without the full complement of Zn2+-binding ligands) domain. Whereas HECT E3s have a direct role in catalysis during ubiquitination, RING and U-box E3s facilitate protein ubiquitination. These latter two E3 types act as adaptor-like molecules. They bring an E2 and a substrate into sufficiently close proximity to promote the substrate's ubiquitination. Although many RING-type E3s, such as MDM2 (murine double minute clone 2 oncoprotein) and c-Cbl, can apparently act alone, others are found as components of much larger multi-protein complexes, such as the anaphase-promoting complex. Taken together, these multifaceted properties and interactions enable E3s to provide a powerful, and specific, mechanism for protein clearance within all cells of eukaryotic organisms. The importance of E3s is highlighted by the number of normal cellular processes they regulate, and the number of diseases associated with their loss of function or Inappropriate targeting.
引用
收藏
页码:15 / 30
页数:16
相关论文
共 50 条
  • [1] Inhibitors for E3 ubiquitin ligases
    John R Lydeard
    J Wade Harper
    [J]. Nature Biotechnology, 2010, 28 : 682 - 684
  • [2] Inhibitors for E3 ubiquitin ligases
    Lydeard, John R.
    Harper, J. Wade
    [J]. NATURE BIOTECHNOLOGY, 2010, 28 (07) : 682 - 684
  • [3] RING Domain E3 Ubiquitin Ligases
    Deshaies, Raymond J.
    Joazeiro, Claudio A. P.
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 : 399 - 434
  • [4] E3 ubiquitin ligases for MHC molecules
    Ishido, Satoshi
    Goto, Eiji
    Matsuki, Yohei
    Ohmura-Hoshino, Mari
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2009, 21 (01) : 78 - 83
  • [5] RBR E3 ubiquitin ligases in tumorigenesis
    Wang, Peter
    Dai, Xiaoming
    Jiang, Wenxiao
    Li, Yuyun
    Wei, Wenyi
    [J]. SEMINARS IN CANCER BIOLOGY, 2020, 67 : 131 - 144
  • [6] E3 ubiquitin ligases and abscisic acid signaling
    Liu, Hongxia
    Stone, Sophia L.
    [J]. PLANT SIGNALING & BEHAVIOR, 2011, 6 (03) : 344 - 348
  • [7] The roles of Pellino E3 ubiquitin ligases in immunity
    Paul N. Moynagh
    [J]. Nature Reviews Immunology, 2014, 14 : 122 - 131
  • [8] Role of E3 ubiquitin ligases in gastric cancer
    Hou, Ya-Chao
    Deng, Jing-Yu
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (03) : 786 - 793
  • [9] Emerging roles of E3 ubiquitin ligases in autophagy
    Kuang, Ersheng
    Qi, Jianfei
    Ronai, Ze'ev
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2013, 38 (09) : 453 - 460
  • [10] E3 ubiquitin ligases and mitosis: embracing the complexity
    Sumara, Izabela
    Maerki, Sarah
    Peter, Matthias
    [J]. TRENDS IN CELL BIOLOGY, 2008, 18 (02) : 84 - 94